For treatment of: Pyracetam nervous system, brainPyracetam nootropics
- For the treatment of internal organs: nervous system, brain
- Appointment: symptomatic treatment of intellectual and mnestic disorders in the absence of an established diagnosis of dementia, reducing the manifestations of cortical myoclonia
- Indications for use: Memory disorders, dizziness, decreased concentration, emotional lability, dementia due to cerebral circulation disorders (ischemic stroke), brain injuries, Alzheimer's disease, in the elderly; comatose States of vascular, traumatic or toxic origin; treatment of abstinence and psychoorganic syndrome in chronic alcoholism; learning disorders in children that are not associated with inadequate training or family environment (as part of combination therapy); sickle cell anemia (as part of combination therapy).
- Contraindications: Hemorrhagic stroke, severe renal failure (with CC<20 ml/min), hypersensitivity to piracetam.
Active substance: piracetam – 400 mg
Excipients: pre-gelatinized starch - 6.0 mg, croscarmellose sodium - 6.0 mg, povidone (polyvinylpyrrolidone) - 10 mg, magnesium stearate - 4.0 mg. Excipients (shell): hypromellose - 7.6 mg, macrogol 4000 - 2.0 mg, titanium dioxide - 4.4 mg.
- Manufacturer: Ozon